Quantitative Evaluation of Chronic Disease Management Policy in China Based on PMC Index Model
- VernacularTitle:基于PMC指数模型的我国慢病管理政策量化评价
- Author:
Siqi ZHAO
1
;
Dongliang LIU
1
;
Yuqi XIA
1
;
Shuzhen CHU
1
Author Information
1. Research Center of National Drug Policy & Ecosystem，China Pharmaceutical Universit y，Nanjing 211198，China
- Publication Type:Journal Article
- Keywords:
Chronic disease management policy;
PMC index model;
Quantitative evaluation
- From:
China Pharmacy
2021;32(13):1627-1633
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE：To su mmarize the achievements and shortcomings of chronic disease management policies in China ， and to provide reference for the formulation and improvement of the policy. METHODS ：Totally 109 documents related to chronic disease management issued by the State Council and various ministries and commissions from 2009 to 2020 were processed by text mining method. PMC index evaluation model of chronic disease management policy was established. Sixteen typical chronic disease management policies were quantitatively evaluated and analyzed by 10 first-level indicators and 40 second-level indicators. RESULTS：Among the 16 policies，10 were of excellent level and 6 were of acceptable level. The average PMC score was 7.243， which was generally acceptable level but still had large room for improvement. By comparing two representative policies ，it was found that the main reasons for the policies with low scores were the lack of long-term development planning ，the absence of “Internet + chronic disease management ”new model and other contents ，and the lack of talent incentive and legal guarantee measures. CONCLUSIONS ：Chronic disease management policy has been improved ，and it can be further improved from the aspects of policy prescription ，policy content and incentive mode.
